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Abstract
Background: People of South Asian-origin are responsible for more than three-quarters of all the smokeless
tobacco (SLT) consumption worldwide; yet there is little evidence on the effect of SLT cessation interventions in
this population. South Asians use highly addictive and hazardous SLT products that have a strong socio-cultural
dimension. We designed a bespoke behaviour change intervention (BCI) to support South Asians in quitting SLT
and then evaluated its feasibility in Pakistan and in the UK.
Methods: We conducted two literature reviews to identify determinants of SLT use among South Asians and
behaviour change techniques (BCTs) likely to modify these, respectively. Iterative consensus development
workshops helped in selecting potent BCTs for BCI and designing activities and materials to deliver these. We
piloted the BCI in 32 SLT users. All BCI sessions were audiotaped and analysed for adherence to intervention
content and the quality of interaction (fidelity index). In-depth interviews with16 participants and five advisors
assessed acceptability and feasibility of delivering the BCI, respectively. Quit success was assessed at 6 months by
saliva/urine cotinine.
Results: The BCI included 23 activities and an interactive pictorial resource that supported these. Activities included
raising awareness of the harms of SLT use and benefits of quitting, boosting clients’ motivation and self-efficacy,
and developing strategies to manage their triggers, withdrawal symptoms, and relapse should that occur. Betel
quid and Guthka were the common forms of SLT used. Pakistani clients were more SLT dependent than those in
the UK. Out of 32, four participants had undetectable cotinine at 6 months. Fidelity scores for each site varied
between 11.2 and 42.6 for adherence to content – maximum score achievable 44; and between 1.4 and 14 for the
quality of interaction - maximum score achievable was 14. Interviews with advisors highlighted the need for
additional training on BCTs, integrating nicotine replacement and reducing duration of the pre-quit session. Clients
were receptive to health messages but most reported SLT reduction rather than complete cessation.
Conclusion: We developed a theory-based BCI that was also acceptable and feasible to deliver with moderate
fidelity scores. It now needs to be evaluated in an effectiveness trial.
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Background
Smokeless tobacco (SLT) is a product containing to-
bacco, placed in the mouth or nose but not burned at
the time of use [1]. Consumed worldwide, a wide variety
of unprocessed (sun-dried), processed or manufactured
products are available, which are either chewed, sucked
or applied to gums and teeth [2]. SLT contains nicotine
and carcinogenic nitrosamines [3] and each year leads to
a loss of more than 6 million Disability Adjusted Life
Years (DALYS) and a quarter of a million deaths [4].
This is due to a higher risk of oral, pharyngeal, and
oesophageal cancers, and fatal myocardial infarction
compared to non-tobacco users [4]. Furthermore, SLT
use leads to gum disease and tooth decay [5]. In women,
its use is associated with reduced gestational age, low-
birth weight and stillbirth [6, 7] and a low bone-mineral
density [8].
More than 300 million adults in at least 115 countries
consume SLT [4]. However, its use is particularly com-
mon in South and South-East Asian regions [9]. For ex-
ample, a quarter of adults in Bangladesh and India use
SLT [10]. In Pakistan, 16.3 % males and 2.4 % females
consume SLT on a regular basis [11]. It is also popular
among South Asian diaspora in the UK; being particu-
larly common among Bangladeshi-origin women (19 %)
and men (9 %) [12]. Being considered as part of their
cultural heritage and family tradition, smokeless tobacco
has social and cultural acceptance among South Asians
[13]. The habit is taken up at a young age as most fam-
ilies equate it to confectionary [14]. Peer pressure, family
acceptance, medicinal use (for dental pain) [15], easy ac-
cess [16], low price, lack of regulation, and media pro-
motion all contribute to its widespread use [17].
Among those using SLT, 33-63 % think of quitting the
habit on their own, although the majority of such at-
tempts are unsuccessful [18–22]. The key factors that
play a significant role in quit initiation and decision
making among SLT users are social support from close
family and friends, media depictions and advice from
doctors/dentists [17]. Other studies have reported peer
pressure and isolation as being the main reasons for re-
lapse among those SLT users who are trying to quit [17].
A Cochrane review, concluded that behavioural support
might be effective in achieving abstinence from SLT
[23]. The review was unsupportive for the use of bupro-
pion and inconclusive for nicotine replacement therapy
(NRT). Varenicline has also been shown to achieve ab-
stinence in people using smokeless tobacco [24]. How-
ever, these trials were mainly conducted in the US and
European populations who, compared to South Asians,
use less addictive and less hazardous products (e.g. moist
snuff ). Therefore, it is not possible to infer the effectiveness
of behavioural support among South Asians in smokeless
tobacco cessation; a knowledge gap acknowledged by NICE
[25]. Moreover, its consumption among South Asians has
strong socio-cultural dimensions, which need to be consid-
ered in behavioural support interventions. The non-trial
data from the UK ‘Bangladeshi Stop Tobacco Project’ sup-
ports the use of behavioural support for smokeless tobacco
[26]. However, the project did not document adapting be-
havioural support to the socio-cultural context of the target
population. The cessation advisors in the UK, offering be-
havioural support to smokeless tobacco users of South
Asian-origin commonly modify their advice, which is
adapted from smoking cessation interventions, according
to what they perceive appropriate. However, there are
variations in practice, no standard treatment protocol
for a culturally adapted intervention and no evidence
for its effectiveness. In addition, Bangladeshi men
using smokeless tobacco have reported being margin-
alised by NHS services [27].
Behavioural support interventions for tobacco cessa-
tion in minority ethnic groups are more likely to be ef-
fective if these take account of their socio-cultural
context and are adapted accordingly. There are some
helpful frameworks to guide systematic cultural adapta-
tion of health interventions for minority ethnic groups
[28]. Consensus has also emerged on the key domains of
behaviour change useful for implementing interventions
[29]. Behavioural determinants have been mapped across
various behaviour change techniques (BCTs) [29]. More
recently, a taxonomy of these BCTs, used and found ef-
fective in health promotion, has been updated [29].
Using these theoretical constructs, we aimed to: (i) de-
velop a bespoke behaviour change intervention (BCI) for
South Asians for SLT cessation by adapting an existing
intervention for smoking cessation, and then (ii) assess
the feasibility of delivering this intervention; recruiting
and retaining participating sites and clients, and collect-
ing data to inform a future trial. We also explored ac-
ceptability of the content and delivery of the BCI as well
as its perceived efficacy.
Methods
The methods used in developing and assessing feasibility
of a behaviour change intervention (BCI) for SLT cessa-
tion followed the Development and the Feasibility/pilot-
ing phases of the MRC Framework for developing and
evaluating complex interventions [30], as follows.
Developing the BCI
Our BCI consisted of a selection of theory-linked BCTs
appropriate for use in South Asian population to help
them quit SLT. The development of the BCI was carried
out in three steps: i) identification and selection of the
key determinants of SLT use among South Asians and
relevant BCTs, ii) translating a list of matched BCTs into
intervention activities and developing a culturally
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appropriate resource to facilitate the delivery of these ac-
tivities, and iii) a post-hoc refinement of this resource.
In the first step, a literature review was undertaken to
identify key theory-based determinants that influence
early uptake and continued use of SLT in people of the
South Asian origin. Using the most up-to-date taxon-
omies of BCTs, these key determinants were mapped on
to the techniques found effective in behaviour change in
general [31] and in smoking cessation [32], in particular.
For building consensus on the most appropriate BCTs, a
modified Nominal Group Technique, in which experts
express their views independently before these are fed
back to the group (usually by means of a facilitator) for
discussion, was used [33]. Two expert panel meetings
were convened, inviting academics and practitioners
with expertise in behaviour change and tobacco cessa-
tion. In meeting one, experts gave scores on a four-point
scale to all SLT determinants on ‘strength of association’
and ‘modifiability’, and indicated their agreement on bi-
nomial scale (Yes/No) to the linked BCTs based on its’
‘efficacy’, ‘acceptability’ and ‘deliverability’. Using an algo-
rithm, scores for ‘strength of association’ and ‘modifiabil-
ity’ were combined for every SLT determinant. For
example, a determinant with no ‘strength of association’
and no ‘modifiability’ was given a score of 1, while on
the other hand, another determinant with high ‘strength
of association’ and high ‘modifiability’ was given a score
of 10. Similarly for BCTs, no agreement on ‘efficacy’, ‘ac-
ceptability’ and ‘deliverability’ received a score of 1, while
agreement on all three received a score of 4. Subse-
quently, average expert scores were calculated for all de-
terminants and BCTs. In meeting two, a full list of
determinants and BCTs was presented with their average
scores. Cut-offs to select the most useful determinants
and BCTs, were established. All determinants scoring 7
or above and all BCTs scoring 3 or above were included.
Those scoring below 6 for determinants and below 3 for
BCTs were excluded. Determinants scoring between 6
and 7 were discussed and included if deemed appropri-
ate by the panel. Following consensus on what was to be
included in BCI, the expert panel proposed how to
translate the final list of determinants and BCTs into the
intervention.
In the second step, key intervention activities were
operationalised as a resource to be used by the tobacco
cessation advisors. This phase of development took place
in a small working group drawn from the expert panel
and supplemented by experts in designing health pro-
motion materials for minority ethnic communities.
Using examples drawn from their experience of working
with South Asian communities, the experts suggested
how best to frame the intervention activities in culturally
appropriate form and content. Mindful of the standard
treatment programme for smoking cessation [34] and a
desire to maintain standardisation, the BCI activities
were categorised and the resource was structured into
pre-quit, quit and post-quit sessions.
The final step in the development of the BCI took
place after assessing its feasibility (see below) and con-
sisted of a review of the activities and the form and con-
tent of the resource by the expert panel. In two expert
panel meetings, participants drew on the field experience
of delivering the BCI to refine the intervention.
Feasibility of delivering the intervention
We assessed the fidelity to the BCI using a pre-defined
index. This consisted of two sub-indices: the Adherence
Index, for assessing compliance to the activities within
the BCI and the Quality Index, for assessing competence
with which the BCI was delivered. Both indices consisted
of a number of items for scoring against a three-point
Likert scale (0 = not implemented, 1 = partially imple-
mented and 2 = fully implemented).
Fidelity data were collected for all participating clients
at the pre-quit, quit and post-quit sessions by audio-
recording their interactions with the advisors. This
method of observation has the advantage of generating
data that are potentially more objective than self-reports
[35] and yet less obtrusive than direct (in-person) obser-
vations [36], which are likely to be susceptible to obser-
vation bias. Due to language variations in client-advisor
interactions between different study sites, three separate
bilingual (English and another South Asian language)
coders were trained on scoring the fidelity index [37] by
listening to audio-recordings. Participant engagement
was assessed by estimating completion rates of the cal-
endars offered at the quit session.
Fidelity data was summarised descriptively but no
comparative statistical analysis was conducted. Partici-
pants receiving the BCI and completing the calendars
were reported as counts and percentages. Fidelity scores
and the duration of pre-quit, quit and post-quit sessions
were presented as means and standard deviations by
study sites (i.e. London, Bradford, Leeds, and Leicester
in the UK, and, Karachi in Pakistan).
Feasibility of recruiting and retaining participants
The feasibility study was conducted in four NHS Stop
Smoking Services (Leicester, Leeds, Bradford and Tower
Hamlets) in the UK and within a community setting in
Karachi, Pakistan. Seven cessation advisors (4 in Tower
Hamlets, 1 in Leicester, 1 in Bradford, 1 in Leeds) in the
UK and one in Pakistan (based at Aga Khan University)
participated in the study. All cessation advisors received
a full-day training session on using the BCI.
A total of 32 adult (≥18 years) regular smokeless to-
bacco users (regular use = at least once in 7 days for
6 months or more) of south Asian-origin were recruited
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(16 in the UK and 16 in Pakistan). We excluded those
who also smoked cigarettes and/or had attended cessa-
tion services in the past.
In the UK, the cessation advisors sifted through their
referrals to identify potentially eligible clients and posted
a participant information leaflet (translated in relevant
south Asian languages – Urdu, Bengali, Hindi and Guja-
rati) to them in advance of their first (pre-quit) appoint-
ment. In Pakistan, potential participants were recruited
through a voluntary sector organisation based in a com-
munity with high use of SLT. Outreach community vol-
unteers identified potentially eligible clients and
provided them with the study information. In both set-
tings, informed written consent was taken at their first
(pre-quit) appointment by our research team.
All participating clients who received the BCI completed
a questionnaire at the pre-quit session (baseline) and pro-
vided a saliva sample for cotinine testing. Cotinine testing
was repeated at 6 months with 28 of 32 participants com-
pleting this. The questionnaire included demographic in-
formation (e.g. age, gender, ethnicity, occupation, medical
history), past and present smokeless tobacco use, past
smoking history, family history, motivation to quit, and
nicotine dependency using translated Oklahoma Scale for
Smokeless Tobacco Dependence (OSSTD) [38], and
Fagerstörm Tobacco and Nicotine Dependency scale for
Smokeless Tobacco (FTND-ST) [39].
Sixteen client participants were also invited to take
part in three semi-structured interviews after their pre-
quit, quit and post-quit sessions. Participants were pur-
posefully selected to ensure equal gender representation
as well as participants from all five sites. They were
given a £10 shopping voucher in the UK and a (equiva-
lent value) food basket in Pakistan for their time. The
advisors who had delivered the BCI were interviewed at
the end of the study.
The aim of the client interviews was to get a detailed
insight on: a) the acceptability of the content and deliv-
ery of the BCI, b) its perceived impact, and c) to make
recommendations for improvement to the BCI. The aim
of the advisor interviews was to explore a) the feasibility
(barriers and facilitators) of delivering the BCI and b)
make recommendations for the post-hoc refinement of
the BCI. Topic guides were developed to mirror the de-
livery of the BCI during cessation sessions (Additional
file 1). Interviews were conducted at GP surgeries, par-
ticipant homes and community centres in the UK, and
at a community outreach centre in Pakistan.
The interviews were audio recorded, translated
(Pakistan interviews) and transcribed verbatim. The
interview data were analysed using content analysis [40].
A categorisation matrix was developed, based on the
aims of this qualitative component and the structure of
the BCI, to which all of the client and advisor data were
coded by a team of three researchers (two UK and one
in Pakistan). The data within each category (e.g. Prod-
ucts Talk, Triggers Talk) were then reviewed and dis-
cussed by these researchers before being written up.
Data for the client and advisor participants were
reviewed separately and then brought together at the
write up stage. Recommendations for the post-hoc re-
finement of the BCI were then taken to the final expert
panel workshops for consideration.
Feasibility of collecting data to inform future trial
Baseline data was summarised descriptively by study
country (i.e. the UK and Pakistan) but no formal statis-
tical comparisons were undertaken. Continuous mea-
sures (e.g. dependency scores) were reported as means
and standard deviations while categorical data were re-
ported as counts and percentages. Based on the saliva
cotinine levels, a cut-off of 15 ng/ml [41, 42] was taken
as confirmation of abstinence from smokeless tobacco
use. The 6-month saliva cotinine results were dichoto-
mised using the cut-off and results of quitters versus
continuing users, and were summarised taking in ac-
count the baseline levels of saliva cotinine.
Results
Developing the BCI
A recently published systematic review provided us with
a list of key determinants of SLT use among South
Asians. Those selected by the expert panel were, lack of
awareness about tobacco and other ingredients con-
tained in the SLT product, lack of information on the
health effects of SLT use, lack of knowledge and miscon-
ceptions on the outcomes expectancies, lack of know-
ledge and ability to self-control (have a self-image, lack
of incentives to quit, lack of self-efficacy to quit and lack
of skills to resist it), and socio-cultural norms (role
models using it and easy access at home and shops).
Other determinants relating to public health issues such
as media influences, lack of regulation and cessation
support, low cost of the products, and socio-cultural
norms such as peer pressure and fear of isolation were
deemed outside the scope of individual face-to-face be-
havioural intervention and thus, were excluded. The
only BCTs excluded were the material incentives/re-
wards for ‘lack of incentives to quit’ and restructuring
the physical environment for ‘easy access at home and
shops’; further details on the BCTs included can be
found in the BCI resource (called BISCA resource).
The BCI resource consisted of an advisor pack (practice
manual and interactive cards) and a client pack (take-home
booklet and 4-week calendar), organised into pre-quit, quit
and post-quit sessions. The advisor pack provided a set of
different scenarios using photographic materials inviting a
dialogue between the advisor and the client. This utilised
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relevant BCTs focusing on: knowledge about tobacco con-
tained in the products, consequences of using it and stop-
ping its use, myths busting; assessment of quit history and
readiness to quit; self-regulatory capacity/skills to deal with
tobacco dependence by facilitating, strategies to manage
the triggers and withdrawal symptoms, monitoring progress
and setting self-incentives. The take-home booklet was a
copy of the interactive cards meant for reinforcement of
the messages delivered in the session, while the calendar
was (offered at the quit session) designed for self-
monitoring.
After piloting the BCI, relatively minor changes were
made. The changes in its content included modifications
in selected images for cultural appropriation, additional
slides on preparation and planning for the quit date and
management of withdrawal symptoms. The structure of
the interactive cards was changed to a flipbook format. In-
formation relating to quit attempt, which was prompted
by the cards, was integrated within a client record form
used by the services. In the flipbook, the key messages and
brief instructions for delivering each image slide appeared
on its back facing the advisor for practical purpose. The
final modifications in the BCI resource were presented to
the expert panel in meeting four, and consensus reached.
It was also agreed to develop a digital application of the
BCI resource for broader outreach.
Feasibility of delivering the intervention
The fidelity index consisted of 29 items - 22 in the Ad-
herence Index, representing BCI content and seven in
the Quality Index, representing competence with which
the BCI was delivered.
The intervention activities related to identifying SLT
products, busting myths and managing triggers were fully
implemented in more than 80 % of the client-advisor ses-
sions, followed by explaining what the product contains,
identifying harmful ingredients and management of trig-
gers - fully implemented in about 70 % of these sessions
(Fig. 1). The intervention activities related to the informa-
tion on nicotine dependence, triggers and withdrawals,
setting rewards, offering client booklets and the scales on
importance, confidence and readiness were the least im-
plemented ones (either not implemented or only partially
implemented); for further detail refer to Additional file 2.
Twelve out of 16 participants from Pakistan completed
and returned the self-monitoring calendars, however,
these were only offered to three participants in the UK
among whom none were collected at the follow-up.
Across the five study sites, the scores for the Adher-
ence Index ranged from 11.2 (SD 2.1) to 42.6 (SD 1.9) -
maximum score = 44; while the scores for the Quality
Index ranged from 1.4 (SD 0.9) to 14 (SD 0) - maximum
score = 14, (Table 1). Similarly, the duration of pre-quit
sessions varied from 4 to 54 minutes, quit sessions from
5 to 35 min and post-quit sessions from 2 to 22 min, be-
tween the five study sites.
Acceptability of the BCI and its Perceived Impact
Content
On the whole, the content of the intervention was per-
ceived positively by clients and advisors in both coun-
tries. The majority agreed that the use of images on the
interactive cards were helpful in portraying behavioural
change messages. Clients demonstrated a particular
interest in the harmful ingredients card and associated
discussion. They commented that this had increased
their knowledge about the harms of SLT use which
many in their community may not be aware of due to
the prevailing myths and misconceptions about SLT
products (Quote BRA004/a, Table 2).
Some clients in Pakistan were unable to relate to a few
images. For example, the images showing commercially
packaged SLT products, which are not sold as such in
Pakistan. (Quote APK001/a, Table 2).
Similar to current evidence [43], some advisors and
clients in the UK felt that there was a need for more im-
ages of negative health consequences alongside positive
images of quitting. For example, images of oral cancer
or dental problems similar to those used on cigarette
packaging might increase clients’ motivation to quit
(Quote BRA004/a, Table 2). In contrast, clients in
Pakistan felt that there should be more emphasis on an
improved appearance after quitting SLT use (Quote
APK001/b, Table 2).
For clients in Pakistan, the main benefit of quitting
SLT use was seen to be financial (Quote APK001/c,
Table 2), whereas in the UK, the emphasis was placed
on health benefits (Quote LEI002/a, Table 2).
Most clients could relate to the examples for managing
urges and avoiding triggers. They found the information
and the coping strategies helpful and useable (Quote
ATH002/a, Table 2). On the other hand, the concept of re-
warding oneself after quitting had divided opinions. Al-
though the picture card on rewards were seen positively;
the majority of clients did not set a reward for themselves
following the quit attempt. The advisor in Pakistan sug-
gested that the majority of clients did not understand the
concept of rewarding oneself (Quote APK001/d, Table 2).
Similarly, in the UK one client suggested that rewarding
oneself in this way is not a concept that the community
can identify with (Quote ALEE001/a, Table 2). Improved
health was seen as a reward in itself.
Delivery
Intervention delivery varied as UK advisors incorporated
the BCI into their current modes of practice whereas in
Pakistan, as there was no pre-existing cessation service,
the intervention was delivered as a standalone activity.
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Table 1 Average fidelity index scores and duration of BCI sessions, by study sites
Site
ID
Fidelity index scores Duration of sessions in minutes
Mean (SDa) Mean (SD)
Nb Adherence Index Quality Index N Pre-quit N Quit N Post-quit
1 5 23.8 (8.4) 11.6 (5.4) 5 23.3 (19.1) 1 12.0 (.) 2 11.4 (2.8)
2 5 11.2 (2.1) 1.4 (0.9) 5 24.1 (4.1) 0 . 0 .
3 2 29.0 (16.9) 10.0 (5.7) 2 41.4 (18.4) 1 35.2 (.) 1 21.4 (.)
4 4 14.8 (3.2) 6.8 (3.8) 4 22.0 (4.7) 1 5.6 (.) 2 7.9 (5.1)
5 16 42.6 (1.9) 14 (0) 16 30.8 (7.6) 16 8.7 (2.9) 15 3.6 (1.5)
aSD is the standard deviation of the mean
bN is the number of participants with data available
Fig. 1 Delivery vs. Intention - the proportions of client-advisor sessions in which different intervention components were delivered
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Table 2 Illustrative Quotes
ID Quote
BRA004/a A: I, I wouldn’t say I actually believe them, but my mother-in-law did say if you eat paan with tobacco it strengthens your teeth,
cos she, her teeth are fine, she got no cavities, they’ve stained a lot, but my mum; when I was small I used to have travel sickness
so she used to say, you know, just the beetle nut on its own, cos it dries out your mouth, cos when you feel sick, you know that
tangy, liquidy thing you get in your mouth?
Q: Yeah.
A: So when you take that it dries out your mouth so you don’t be sick; and I did used to take it, I can remember, yeah, so.
Q: Yeah. Is that a common belief amongst Bengali communities?
A: Yeah, it is. But they said, you know, if you have, my mother-in-law says if you have, you know, tooth aches or pains in your
tooth or gum to chew with tobacco. She’s told me, she, cos I’m, I have very weak gums and she tells me “Oh, you know, the
raw tobacco leaf” she says “oh eat with that”. I said “No mum, I can’t eat that cos it’s really, really strong”. Cos with this, it’s not
just tobacco, there’s a lot of other things in it like that, so.
Female Client, UK
APK001/a Like, yeah, to grade their readiness. And, OK, so, OK, and with card number one, I don’t think this really represented the type of
tobacco they used very well; cos I like, I showed them this card and I was like “Which one do you use?” And they would say “Oh
we use gutka, we use naswar”. And then I’d point to gutka in the picture, I’d point to naswar, I’d say “Oh this is naswar and this
is gutka”. And they’re like “No, but this isn’t the type we use” and everything. So maybe I, I think maybe this was more oriented
towards the England wing of the study where like this is what it looks like over there, whereas over here it doesn’t really look like
that… it’s not very all, it’s not all that commercial, like everyone makes their own at home and everything, so it’s not very
packaged, very professionally.
Advisor, Pakistan
BRA004/a Yeah, this is, just telling you what’s in it, yeah, that I think they will really take notice of that card, and you know like if you have
actual pictures of actual things that can happen; cos in one of the tins that come from Bangladesh recently it’s got the picture,
her grandfather gave to her father, it’s literally a man with a picture of cancer in his mouth with a big tumour. Every time I pick
it up I just put it down; and she says “Chuck it away, chuck it away”. Cos you know if, if you have pictures like that it literally does
make you not want to take that.
Female Client, UK
APK001/b Yes, that was important to a certain extent, where I’d point out that “Oh, you know, once you stop smoking your teeth will look
better, you will feel better”. And that one was a factor in certain patients where they, because we’re a population that’s obsessed
with the tone of our skin, so they were just obsessed that, oh yeah, we will, like when I wasn’t using tobacco I used to be fairer
so I’m gonna become fairer now and my teeth are gonna look better and everything; and then when some of them did stop and
they came back for their third session their teeth did look better, they were very proud, proud of that fact, oh look at our teeth,
they look so nice and everything. And then there was actually one client that even went and got his cleaned out and everything
afterwards; so that was, yes.
Advisor, Pakistan
APK001/c Yes and no, because I feel like the main driving force behind the fact that most of the patients were motivated to quit was because
we were motivating them. Like most of the patients were motivated because we talked about, oh OK, so tell me why you wanna
quit? So most of them wouldn’t bring up the fact that it causes mouth cancer, they’d be like, oh we, because we’re spending too
much money on this and we’re poor and we wanna pay our children’s school fees and everything. So that was why this was so
effective, because they weren’t leaving it because they were scared, because I feel like that’s scare factor, and like maybe even as a
doctor, like you can only scare patients so much until that becomes redundant and just becomes, OK fine, so maybe this just might
happen, so what, you know?
Advisor, Pakistan
LEI002/a For me, I guess you, you know, you’ve got the health one there, that, that’s probably the main important, maybe emphasise a bit
more on that and, and what, what are the harmful effects. For example, one of the things that made me go to the dentist is because
my teeth discoloured and my gums started to drop as well. So after a lot of use, he’s told me that chances are the gums won’t grow
again, but he’s certainly got’em all clean, and thank goodness, I’m grateful that I didn’t have any illness, cos I thought I had an illness
on the back of that.
Male Client, UK
ATH002/a This [card10] is a good one, I think, yeah, sometimes when you talk to them you can’t always explain it, but these, these pictures are
quite self-explanatory, like people can look at it and understand what other things they can do to, that will help them give up here…
These, these are very good ones, these are very good ones. So maybe you can, for women you can think of like, you know, for Muslim
or reading Koran or, or like if they’re a bit younger then maybe going to swimming; because they do love swimming, a lot of people
love going to swimming; so maybe we can put that.
Advisor, UK
APK001/d Maybe they needed a better idea of what a reward meant, like I felt like I had to pump them a little; like “OK, a present for yourself,
like you can get new clothes.” “Oh yeah, we’ll get some.” But then they were just like agreeing with whatever I was saying, and then
when I asked them later on they didn’t, they didn’t even understand what I, what I was trying to ask them.
Advisor, Pakistan
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Table 2 Illustrative Quotes (Continued)
ALEE001/a For some people it will be. I think maybe for a lot of Bangladeshi women it’s, not necessarily, cos I, I think they find it hard to know
what they would reward themselves with, so, cos they wouldn’t actually go out and buy loads of clothes or; we did talk about
maybe having a massage or something like that, I think. I think I suggested possibly because of the, she’s not gonna have the lip
staining, maybe buying a lipstick (laughs) or something. But I, I think she found it really difficult to think of a reward; so we didn’t
really discuss that, I don’t think.
Advisor, UK
ALEI001/a I think just to give it, them just a couple of weeks; abrupt is usually better in a, in some ways, because there’ll never be a right time
or a date for them to stop, but I think just to give them just those two weeks, just to, for them to think about it and absorb everything
what we’ve talked about, I think that will give you a result instead of just saying this is it and people don’t really relate to that
Advisor, UK
ATH002/b Only behaviour support might not work because none of us are trained counsellors; even the trained counsellors would find it
difficult, with the counselling, to change somebody’s behaviour, and within two, four weeks or eight weeks would not be possible.
So I think you do need the, the NRT products, they, they play an important role and a big part, and people think oh it’s like medicine,
that might help me; not, it’s not true for everyone but for eighty percent, eighty to ninety percent of our client they go for the NRT
support and it does help them and, or sometimes it could be psychological, you know, they think that, OK.
Advisor, UK
ATH001/a I think a lot of clients they tried to give up through will-power and they haven’t succeeded. Obviously because of my previous
experience, NRT has been effective and quite a lot of clients they want some form of product to help them stop chewing tobacco
because otherwise how the perception is, “if it’s just behavioural support I can just get my friend to support me, I don’t need an
advisor”, so I think they just want a combination of maybe NRT and behavioural support.
Advisor, UK
ALEI001/b I think the cards itself are too simple and sometimes you can probably do it in verbal with the client and you don’t really need
to show them a picture, I feel, but sometimes it does jog a memory; some things they would say that I’ve, I’ve experienced, they
would say I probably haven’t even noticed…. Optional I would say; if it works for some people, fine, but I think you, it shouldn’t
be a necessary that you need to use them, yeah.
Advisor, UK
ATH001/b Um I would say maybe a bit of both but I think a lot of clients they’re short for time, so they’re not able to spend that much time
with you and, yeah I think the cut down definitely on the resources, make it shorter and maybe, I don’t know, maybe group things
together in a nutshell.
Advisor, UK
ALEI001/c I think it was just off-putting using the, the, this resource with the card, for me personally, I think it was too confusing. I think if you
got the assessment form done it would be much easier…. For me it isn’t working, it was too complicated. I couldn’t give, I felt I
couldn’t give the, the client all that attention that I would normally give. As a smoker, let’s say, we would look at them and while
they’re talking we’ll be going through the form and remembering what they’ve said so you’re not duplicating questions as well, so
you’re just writing, everything’s on the form, any additional you can write, you know, down. So, you know, it’s like a memory isn’t
it then? Maybe we can have the handbook just for ourselves and, but assessment form is really essential.
Advisor, UK
APK001/e So I think that way the resource was great. The only issue that I think the participants had and I think with, and maybe I has as well,
with the resources, when we have to ask them to grade, like for example, like oh tell me from 0 to 10 how ready do you think you
are to stop smoking this and everything; so the thing was they weren’t quite understanding this grade skill, and I think that’s just an
issue with this resource; I think even as a doctor, when we ask patients about like to grade their pain on a pain scale, they face the
same issue where they, they automatically just pick 10 or they pick 0, there’s no middle ground in the middle, yes… So I had this
issue with one of the participants, the one, he didn’t actually commit to quit, so, all right, he didn’t actually quit, so, but then I was
like “Oh how ready are you to stop using tobacco and everything?” And he said “10, 10, 10”. And then at the end of it I was like
“OK, so are you ready to stop now?” And he was like “Oh no, I’m not ready to stop”. (Q laughs) …maybe if we had like a reference
for each number maybe he would have understood more, maybe he would have told me, oh 4 or 3, 5 or something like that,
so yeah.
Advisor, Pakistan
LEI002/b As I say, it’s a first time that I’ve come into something like this; so it’s been helpful that I can actually admit to the fact that I am
addicted and I need to do something about it and, as I said, I’m, I’m reliant on, I’m gonna rely on the things that she’s offering
me, that it’ll help me in my journey.
Male, Client, UK
APK001/f Yeah the majority of them had quit for like a few days, right, so when they came at this point in time they were experiencing
very, very severe withdrawal symptoms, like I mean I’ve seen people in withdrawal but those are very similar. So there is this one
theory that I have, and like it’s, this story is based on the information I’ve got from the patients, they say that the tobacco they
have, or whatever form they have it in, it’s just not tobacco, there are several other illicit substances involved. So one of the men
actually claimed that there was, what he says was (genus?) in it, which I, I think that’s heroin or cocaine in it or something like that,
but this is just one person saying this to me. So that was an issue at this point because some of the women who quit, they were
just visibly dizzy, like they were just sitting there and they were like this, like I could tell (Q laughs) that they were out of it really,
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In the absence of any specific guidelines for SLT cessa-
tion, most UK advisors felt that a gradual reduction
worked better than an abrupt cessation (which was the ap-
proach advocated in the BCI) (Quote ALEI001/a, Table 2)).
All the UK advisors and the majority of the UK clients felt
that information on nicotine replacement therapies
(NRTs) should be included in the BCI as it is routinely of-
fered to clients (although there is no scientific evidence of
their effectiveness for SLT users) [43] and is an important
part of the service that they offer (Quote ATH002/b,
Table 2). Advisors felt that prescribing or advising on
NRTs further motivates clients to quit (Quote ATH001/a,
Table 2). Participants in Pakistan did not comment on this
as NRTs are not currently available there.
Some UK advisors argued that the use of picture cards
should only be used if the advisor deemed it necessary.
They felt that for some clients, the resource might be
delivered verbally only (Quote ALEI001/b, Table 2).
Finally, many UK advisors suggested changing the
structure of the resource to improve its deliverability
and reduce the duration of the pre-quit session,
which some clients also felt, was too long (Quote
ATH001/b, Table 2). A few also suggested that com-
bining the handbook and the interactive cards into a
single tool might facilitate intervention delivery. A
few of the advisors in the UK stressed that there is a
need for an assessment form to complement the re-
source (Quote ALEI001/c, Table 2).
Perceived efficacy
All clients reported that they felt highly confident
and motivated to quit SLT scoring seven and above
(scale of 1–10) on a confidence and readiness to quit
scale at the pre-quit and quit sessions. However,
there were some concerns among advisors regarding
the scales who felt that clients didn’t necessarily
understand what they represented and were simply
scoring highly to please the advisor (Quote APK001/
e, Table 2).
There was also strong motivation among clients fol-
lowing the pre-quit session to quit SLT use based on
the information they received in the session (Quote
LEI002/b, Table 2). After the post-quit sessions, the
majority still emphasised a general desire and ability
to quit however some described the challenges of
quitting abruptly and had relapsed or decided on a
gradual reduction approach rather than abstinence.
Clients in Pakistan particularly reported a high degree
of withdrawal symptoms, which may have impacted
on their motivation to remain abstinent (Quote
APK001/f, Table 2).
Recommendations for improving the BCI
Client and Advisor suggestions for refining the BCI are
presented in Table 3 along with post-hoc refinement that
occurred.
Table 2 Illustrative Quotes (Continued)
so yeah, like one was just like just not even there, like she was barely comprehending what I was saying, you know, in the end like
she actually, we had to actually take a break in the middle of it. “OK, how about you take five and everything, go and take a glass
of water.” But they were visibly, visibly, visibly out of it; so they
were experiencing very severe withdrawals… Maybe this can be like a potential like confounding factor where we’re gonna have
a lot people coming here and who don’t quit. Because if there are other illicit substances involved, because our resource is only
for tobacco, you know, and like when it comes to like whatever illicit substance is there like, you know, even if it’s like cocaine,
heroin, marijuana like you need other resources there, you know, like maybe you have to give them medication or like they need
to go to hospital or something like, but by the end of it, four weeks later it was not a factor I think, like, yeah.
Advisor, Pakistan




Advisors in the UK stressed that there is a need for an
assessment form to complement the resource (ALEI001/d).
We have developed a form where advisors can record information
about their clients to complement the resource and assist with data
collection for their services.
Layout and
structure
Advisor participants suggested combining the handbook
and picture cards together to improve deliverability.
We restructured the resource and developed a flipbook so that the
guidance note for the advisor appears at the back of each picture
card.
Content The majority of UK participants felt that information on nicotine
replacement therapies (NRTs) should be included in the resource
as it is routinely offered to clients and is an important part of the
service that they offer (ATH002/b). Advisors felt that prescribing or
advising on NRTs further motivates clients to quit (ATH001/b).
Participants in Pakistan did not comment on this as NRTs are not
currently available there.
AS there is no scientific evidence of the effectiveness of NRTs in SLT
users, we have not included NRT support at this stage within the
resource.
A number of other suggestions were made on the contents from participants throughout the BCI. All these detail specific recommendations were incorporated
within the BCI when refined
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Feasibility of recruiting and retaining participants
We successfully recruited all 32 participants, 16 in the
UK (5 in Tower Hamlets, 5 in Bradford, 2 in Leeds, 4
Leicester) and 16 in Karachi, Pakistan. All 32 partici-
pants received the intervention and provided baseline
data including saliva sample for cotinine test. However,
only 64 % (23/36) completed full six-month follow up -
10/16 in the UK and 13/16 in Pakistan.
Feasibility of collecting data to inform future trial
Baseline questionnaires took 30–60 min to complete. All
questionnaires in Pakistan were completed in full. In the
UK, 12 questionnaires were completed in full and 4 were
partially completed due to participant time constraints.
There were some data missing from several sections; for
the Fagerström Scale, four UK participants did not
complete any of the scale and one participant missed
one item on the scale for which imputation was carried
out by averaging the responses to the same item by all
participants. The score (within Fagerström scale) was
imputed for this item before summarising the overall de-
pendence score. 9.4 % (n = 3) were missing for aids to
help quit and 3.1 % (n = 1) for intention to quit, 18.8 %
(n = 6) for advice to stop using SLT and assistance to
stop. We were able to collect the fidelity data from the
audio recordings for 32 participants at the pre-quit, 19
at the quit and 20 at the post-quit sessions.
Table 4 compares the characteristics of the study par-
ticipants at the two study sites. Nearly all participants in
the study used SLT on a daily basis (n = 30 [93.8 %]). In
Pakistan, a higher quantity of SLT used per day (mean
17.7 [SD: 12.34]) compared to the UK (mean 9.56 (SD:
9.65)). The two most popular forms of SLT were tobacco
leaf or tobacco leaf mixture in the UK, and Gutka or to-
bacco, betel nut and catechu mixture in Pakistan
(Table 4).
Participants in Pakistan appeared to be more addicted
to SLT, with 56.3 % (n = 9) scoring very high and 37.5 %
(n = 6) scoring high on the Fagerstrom dependence scale,
compared to the UK, where 6.3 % (n = 1) participants
scored very high and 12.5 % (n = 2) scored high (Table 4).
For all participants where some answers were not given
on the scale, imputations were performed.
All participants intended to quit, although these were
over different time frames (Table 4). 34.4 % (n = 11) have
attempted quitting in the last year (UK n = 8 [50 %],
Pakistan n = 3 [18.8 %]). Some participants, especially in
Pakistan, were being asked about their SLT use and en-
couraged to stop (Table 4), however, only one participant
(3.1 %) was offered any support to stop using SLT, this
participant was from the UK.
Cotinine measurement was done at baseline and at
follow-up at 6 months with one participant in Pakistan
and six in the UK not completing the follow up.
Cotinine levels were found to be higher in the Pakistan
population. In the UK, the mean saliva cotinine was
237.1(SD: 194.62) ng/mL. In Pakistan, urine cotinine
sticks were used, with all but one participant having a
level 6, the equivalent of >2000 ng/mL. At the 6 month
follow up only 10 participants in the UK took the
6 month follow up test, with a lower average mean score
of 174.3 (SD: 220.7). In Pakistan, 13 participants com-
pleted the follow up. There were no delays in data col-
lection concerning baseline or follow-up, including the
cotinine testing.
In Pakistan, all of the planned interviews (n = 8) were
conducted following the pre-quit, quit and post-quit ses-
sions. In the UK all of the planned interviews (n = 8)
were conducted at pre- and post-quit. However, follow-
ing the quit sessions, only two interviews were com-
pleted. This was because most of the UK advisors did
not set a quit date with their clients and preference was
given to a gradual reduction in SLT use rather than an
abrupt cessation. As such six participants did not receive
quit sessions. Eight advisors were interviewed (seven in
UK and one in Pakistan) who had delivered the BCI at
least once with clients.
Discussion
Our study is the first attempt to design and conduct an
early-phase evaluation of a bespoke behaviour change
intervention for SLT cessation among people of South
Asian-origin. Literature searching and expert consensus
helped us to identify the BCTs required to make a to-
bacco cessation intervention more effective, feasible, and
acceptable for South Asians. Design experts and tobacco
cessation advisors working with South Asian communi-
ties assisted us in translating these techniques into an
interactive and culturally appropriate educational re-
source, both in paper and electronic format. When we
implemented this intervention albeit in a limited number
of clients, we found high levels of fidelity in both adher-
ence to the specified BCTs and quality-related criteria
and most BCTs were implemented to their full extent.
Both advisors and clients found the content of the inter-
vention appropriate and mode of its delivery feasible.
Most clients found images in the resource materials mo-
tivational and messages helpful in making an intention
to quit. The intervention also appeared to boost their
confidence in their abilities to quit and provide them
with strategies to cope with their nicotine urges. Our
study also showed high levels of clients’ engagement
with the intervention, their ability to relate to resource
images and their willingness to participate in related re-
search activities. Differences were also observed between
clients in Pakistan and in the UK particularly in relation
to levels of nicotine dependence, intention to quit, previ-
ous quit attempts and cessation advice received in the
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Table 4 Descriptive statistics of participant characteristics
Characteristics Total UK Pakistan
Total, N 32 16 16
Sex, n (%)
Male 16 (50) 8 (50) 8 (50)
Female 16 (50) 8 (50) 8 (50)
Current SLT use daily vs. non-daily, n (%)
Daily 30 (93.8) 15 (93.8) 15 (93.8)
Non- daily 2 (6.3) 1 (6.3) 1 (6.3)
Current SLT use times per day, mean (SD) 13.6 (11.7) 9.56 (9.7) 17.7 (12.3)
Type of SLT used, n (%)
Tobacco leaf or tobacco leaf mixture 11 (34.4) 8 (50) 3 (18.8)
Gutkha or tobacco, betel-nut & catechu mixture 23 (71.9) 7 (43.8) 16 (100)
Urge to use SLT, n (%)
Not at all 4 (12.5) 0 (0) 4 (25)
A little of the time 5 (15.6) 1 (6.3) 4 (25)
Some of the time 14 (43.8) 7 (43.8) 7 (43.8)
A lot of the time 6 (18.8) 5 (31.3) 1 (6.3)
Almost all the time 2 (6.3) 2 (12.5) 0 (0)
All the time 1 (3.1) 1 (6.3) 0 (0)
Strength of urges for SLT, n (%)
No urges 4 (12.5) 0 (0) 4 (25)
Slight 1 (3.1) 1 (6.3) 0 (0)
Moderate 10 (31.3) 6 (37.5) 4 (25)
Strong 12 (37.5) 6 (37.5) 6 (37.5)
Very strong 5 (15.6) 3 (18.8) 2 (12.5)
Extremely Strong 0 (0) 0 (0) 0 (0)
Fagerström Scale - SLT, n (%)
Very Low (0–2) 2 (6.3) 2 (12.5) 0 (0)
Low (3–4) 5 (15.6) 5 (31.3) 0 (0)
Moderate (5) 3 (9.4) 2 (12.5) 1 (6.3)
High (6–7) 8 (25) 2 (12.5) 6 (37.5)
Very high (8–10) 10 (31.3) 1 (6.3) 9 (56.3)
Quit intentions, n (%)
May quit in future, but not in 6 months 9 (28.1) 0 (0) 9 (56.3)
Will quit in the next 6 months 10 (31.3) 4 (25) 6 (37.5)
Will quit in the next 30 days 12 (37.5) 11 (68.8) 1 (6.3)
Quit attempt in last 12 months, n (%) 11 (34.4) 8 (50) 3 (18.8)
Use of any tobacco cessation aids, n (%) 2 (6.3) 2 (12.5) 0 (0)
Doctors asked about SLT use, n (%) 13 (40.6) 3 (18.8) 10 (62.5)
Doctors advised to stop SLT use, n (%) 10 (31.3) 3 (18.8) 7 (43.8)
Doctors offered aids to quit, n (%) 1 (3.1) 1 (6.3) 0 (0)
Smoked 100 cigarettes in lifetime, n (%) 1 (3.1) 1 (6.3) 0 (0)
UK population – saliva cotinine concentration ng/ml Baseline Follow-up
N 16 10
Min 1.0 0.1
Siddiqi et al. BMC Public Health  (2016) 16:501 Page 11 of 15
past. While mean cotinine levels among our participants
show a slight reduction at the follow-up compared to
baseline, a higher maximum range indicates that a few
might have increased their SLT use (Table 4). However,
given the sample size insufficiency, no statistical infer-
ence should be made based on these findings.
While we found many similarities between our find-
ings and those from studies of cigarette smoking, we
also observed interesting differences between the two. A
comprehensive evidence review of BCTs highlighted that
identifying triggers for smoking and strategies to cope
with these triggers are effective techniques for smoking
cessation [44]. Likewise, our clients also found that ac-
knowledging potential triggers for using SLT and strat-
egies to deal with these triggers were helpful in building
their self-efficacy for quitting. Concerns about stigmatis-
ing of certain social classes by depicting a negative por-
trayal of a smoker [45] has led to an increased emphasis
on a positive image of an ex-smoker [46] in anti-
smoking educational materials. However, our client co-
hort found negative portrayal of SLT users and graphic
images of the health effects of SLT use compelling and
motivating. This is also inline with the evidence that
suggest that emotive and graphic imagery in anti-
smoking campaigns is effective in generating an emotive
response and an intention to quit [47–49]. Our findings
highlight that a negative portrayal of SLT use could also
be useful in ‘myth busting’ and challenging beliefs, often
rooted in culture and lived experience, about the ‘posi-
tive’ expectancies of SLT use [17]. Self-reward while con-
sidered as an efficacious incentive to change behaviour
[50], did not appear to be influential among our clients.
Likewise, while there has been some success in challen-
ging people’s perceptions by proposing that risky smok-
ing behaviours are not accepted social norms [51]; this
approach did not resonate with the clients using SLT.
This might be because SLT use, unlike cigarette smok-
ing, is still a social norm in certain sub-cultures to which
our clients belonged [52]. Contrary to the standard
practice, our advisors in the UK were reluctant to advice
abrupt cessation, which they considered as a potential
barrier to client engagement. Given that the latest
Cochrane review comparing reduction versus abrupt
cessation concluded that both approaches can be effect-
ive [53], a gradual reduction approach needs further
examination for quitting SLT. Finally, our clients did not
relate to using numeric scales to gauge their readiness to
or confidence in quitting. We don’t fully understand the
reasons for this but suspect that it might be linked to
poor health literacy in Pakistan and in minority ethic
communities in the UK [54].
Our study has several strengths. This is one of the few
studies attempting cultural adaptation of an intervention
to address a behaviour that is steeped in respective
socio-cultural context. As we modelled components of
BCI, we also developed a fidelity index that mapped
across the intervention theory. We measured fidelity and
provided an analytical approach, which can be used not
just to measure fidelity but also to assess the relative ef-
fectiveness of the different components of the interven-
tion. By conducting implementation research, both in
Pakistan and the UK, we enhanced the external validity
of our study. It also provided opportunities to share ex-
periences and study differences between the two popula-
tions. Finally, by tackling a health issue that primarily
affects women of a minority ethnic group in the UK, the
study addressed health inequalities and offered oppor-
tunities to engage with marginalised communities. Our
study also had some limitations. We were limited in our
theoretical adaptation of BCTs for South Asian clients,
by a handful of studies. Furthermore, we did not collect
primary data on community perceptions directly from
our target population before developing the intervention
and rather relied on the literature reviews. Our sample
size was small to make any statistical inference, albeit
sufficient for an in-depth feasibility study of this nature.
Our method of observation was based on audio-
recordings only and could have missed visual clues on
Table 4 Descriptive statistics of participant characteristics (Continued)
Max 577.1 609.0
Mean (SD) 237.1 (194.62) 174.3 (220.7)
Pakistan – urine cotinine level (cotinine equivalent ng/mL) Baseline Follow-up
0 (1–10) 0 0
1 (10–30) 0 0
2 (30–100) 1 0
3 (100–200) 0 0
4 (200–500) 0 6
5 (500–2000) 0 1
6 > 2000 15 6
Missing 0 3
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rapport building and body language between clients and
the advisors. We were mindful of but could not account
for, the differences between contrasting health-systems
in Pakistan and in the UK. While the UK study sites
were offering an on-going tobacco cessation service for
SLT users, no such service existed in Pakistan. Likewise,
NRT, although not part of BCI, was available to the cli-
ents in the UK. This was not the case in Pakistan. Due
to the absence of a cotinine-testing lab in Pakistan, we
were limited to using cotinine strips to assess SLT use
there. While we understood that there are dual tobacco
users (more among men than women of South Asian-
origin), we did not include them in our study. However,
we propose that integrating BISCA intervention with
smoking cessation intervention and testing it in dual
users would be an important and logical next step.
Conclusions
We expect to have developed a culturally appropriate
behavioural intervention that could prove to be an ef-
fective tool in helping SLT users of South Asian-origin
in quitting SLT use. Our study provides a methodo-
logical basis for designing future randomised controlled
trials evaluating a behaviour change intervention for SLT
cessation either alone or in combination with other
pharmacological agents. Ours’ was part of the very first
cohort of studies funded by the UK Medical Research
Council’s new Public Health Intervention Development
Scheme aimed at stimulating innovation in public
health. We hope to have made a positive contribution to
the overall aims of this programme by advancing
methods for culturally adapting complex interventions,
and assessing their fidelity, acceptability, and
appropriateness.
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